96693 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being basic Arg-amino acid
MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION
#2CRYSTALLINE DIPEPTIDES USEFUL IN THE SYNTHESIS OF ELAMIPRETIDE
#3AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#4AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#5TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#6SELECTIVE SMALL MOLECULE AGONISTS AND PARTIAL AGONISTS OF TRK RECEPTORS
#7PSMA-TARGETED NIR DYES AND THEIR USES
#8POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF
#9MITOCHONDRIA-TARGETING PEPTIDES
#10Crystalline dipeptides useful in the synthesis of elamipretide
#11Mitochondria-targeting peptides
#12INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#13DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF
#14CSF1R-BASED CHIMERIC PROTEINS
#15AMINO ACID COMPOSITION HAVING CO-AMORPHOUS STRUCTURE
#16PSMA-TARGETED NIR DYES AND THEIR USES
#17Transfection complexes and methods of using the same
#18NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME
#19Crystalline dipeptides useful in the synthesis of elamipretide
#20METHOD FOR PRODUCING AMIDE
#21AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#22PSMA-targeted NIR dyes and their uses
#23Aromatic-cationic peptides and uses of same
#24NMDA ANTAGONIST PRODRUGS
#25Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#26Crystalline dipeptides useful in the synthesis of elamipretide
#27CSF1R-based chimeric proteins
#28CSF1R-CD40L chimeric proteins
#29N-carboxyanhydride-based-scale synthesis of elamipretide
#30CSF1R-based chimeric proteins
#31NMDA antagonist prodrugs
#32PSMA-targeted NIR dyes and their uses
#33AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#34THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#35AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#36FLUOROUS COMPOUND, METHOD OF PREPARING FLUOROUS TAGGED PROTEIN, AND METHOD OF IMMOBILIZING PROTEIN
#37Antimicrobial peptidomimetics
#38Transfection complexes and methods of using the same
#39NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME
#40Selective cysteine protease inhibitors and uses thereof
#41Inhibitors of growth factor activation enzymes
#42Pro-Amb reverse turn restricted bioactive peptide analogues
#43NMDA antagonist prodrugs
#44PSMA—targeted NIR dyes and their uses
#45Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#46PSMA-targeted NIR dyes and their uses
#47Tripeptide compound, preparation method therefor, and application thereof
#48Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#49Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#50PSMA-targeted NIR dyes and their uses
#51PSMA-targeted NIR dyes and their uses
#52Antimicrobial peptidomimetics
#53NMDA antagonist prodrugs
#54Method for producing dipeptide derivative containing disubstituted amino acid residue
#55Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#56Liquid automatic dish washing detergent compositions
#57Active Agent Prodrugs with Heterocyclic Linkers
#58AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION
#59Process for producing self-assembling peptide derivatives
#60Peptides and use thereof
#61Substrates and inhibitors of prolyl oligopeptidase and methods of use
#62AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#63Derivatives of hemin with antibacterial and antiviral activity
#64Cyclin based inhibitors of CDK2 and CDK4
#65Stabilized subtilisin composition
#66Method of producing peptide
#67Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#68Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#69Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#70Selective cysteine protease inhibitors and uses thereof
#71AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#72C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#73Immunoconjugates, compositions for making them, and methods of making and use
#74MACROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS FOR PREVENTING OR TREATING HIV INFECTION
#75Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
#76Method of treating tumors
#77Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#78PEPTOID COMPOUNDS
#79Substrate peptide sequences for plague plasminogen activator and uses thereof
#80AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION
#81COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS OF ACTIVE AGENTS AND INHIBITORS THEREOF
#82Oligomeric biosurfactants in dermatocosmetic compositions
#83Peptide derivative and composition for promoting tear secretion comprising the same
#84Casein hydrolyzate, process for producing the same and use thereof
#85Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof
#865-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
#87Substrate for assaying β-glucan and/or endotoxin and assay method
#88BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#89PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF
#90Antimicrobial compounds and formulations
#91ANTIMICROBIAL COMPOUNDS
#92PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES
#93PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER
#94PEPTOID COMPOUNDS
#95Prober cleaning block assembly
#96AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION
#97AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF
#98N-Methylation of amino acids
#99Peptide derivatives useful as antimicrobial agents and for treating wounds
#100Method of producing peptide
#101Substrate peptide sequences for plague plasminogen activator and uses thereof
#102Cationic amino acid type lipid
#103Protease inhibitors for coronaviruses and SARS-CoV and the use thereof
#104C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#105Casein hydrolyzate, process for producing the same and use thereof
#106α-MSH-antagonist dipeptide conjugates
#107Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
#108Biogically non-degradable peptides, angiostensin converting enzyme inhibitor, drug and functional food
#109Peptoid compounds
#110Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#111Acylated 4-amidino- and -4-guanidinobenzylamines for inhibition of plasma kallikrein
#112Antimicrobial compounds
#113Amino acid derived prodrugs of propofol, compositions and uses thereof
#114Substrates for TAFI (A)
#115Heteroaryl peptidomimetics as thrombin receptor antagonists
#116Suppression of immune response via inhibition of cathepsin S
#117Suppression of immune response via inhibition of cathepsin S
#118Peptoid compounds